EntreMed Inc (ENMD)

0.90
0.00 (0.00)
NASDAQ : Health Care
Prev Close 0.90
Open 0.93
Day Low/High 0.90 / 0.94
52 Wk Low/High 0.83 / 2.13
Volume 23.05K
Avg Volume 20.80K
Exchange NASDAQ
Shares Outstanding 27.04M
Market Cap 47.05M
EPS -0.22
P/E Ratio N/A
Div & Yield N.A. (N.A)
EntreMed Dodges Funding Bullet

EntreMed Dodges Funding Bullet

The company enters a licensing pact with Celgene worth about $27 million.

EntreMed Reports Positive Results for Its Cancer Treatment

EntreMed Reports Positive Results for Its Cancer Treatment

The biopharmaceutical company says its treatment for blood cancer has shown positive results.

Pharmacia Stops Testing on Cancer Drug

The company says SU5416, one of the first antiangiogenesis drugs, wasn't working.

Genentech's Avastin Might Renew Interest in Tumor Battle

Three years after an overhyped rollout, drugs that attack tumors' blood supplies are making progress.

Biotech Start-Up Banks on Big Names as IPO Approaches

Biotech Start-Up Banks on Big Names as IPO Approaches

GMP boasts an ample supply of biotech stars but little in terms of revenue or product. Is this market ready for this deal?

How To Read Charts, Part 3

How To Read Charts, Part 3

By reader demand, a few more tricks of the TA trade.